Have a personal or library account? Click to login
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences Cover

Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences

Acta Pharmaceutica
Volume 73 (2023): Issue 2 (June 2023)
By: Javier Muriel,  Mónica Escorial,  César Margarit,  Jordi Barrachina,  Cristian Carvajal,  Domingo Morales and  Ana M. Peiró  
Open Access
|Jun 2023

Metrics

DOI: https://doi.org/10.2478/acph-2023-0018 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 227 - 241
Accepted on: Nov 17, 2022
Published on: Jun 12, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
chronic pain,
drug deprescription,
opioid use disorder,
long-term monitoring,
pharmacogenetics,
sex differences
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Javier Muriel, Mónica Escorial, César Margarit, Jordi Barrachina, Cristian Carvajal, Domingo Morales, Ana M. Peiró, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 2 (June 2023)Next article